Phase I/II study of adjuvant immunotherapy with sentinel lymph node T lymphocytes in patients with colorectal cancer

Phase I/II study of adjuvant immunotherapy with sentinel lymph node T lymphocytes in patients with colorectal cancer

Although the development of multi-disciplinary management has improved the survival of colorectal cancer (CRC), the prognosis of metastatic CRC patients remains poor. Accumulating evidence has demonstrated that immunotherapy with cancer vaccines and adoptive T cell transfusions may improve outcomes...

Full description

Bibliographic Details
Main Authors: Zhen, Yun-Huan, Liu, Xiao-Hui, Yang, Yuan, Li, Bo, Tang, Jing-Ling, Zeng, Qiang-Xing, Hu, Jie, Zeng, Xing-Nan, Zhang, Lu, Wang, Ze-Jun, Li, Xiao-Yun, Ge, Hui-Xin, Winqvist, Ola, Hu, Ping-Sheng, Xiu, Jin
Format: Online
Language:English
Published: Springer Berlin Heidelberg 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540776/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540776/

Similar Items